Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2012
08/09/2012WO2012106427A2 Methods for treating diabetic foot ulcers
08/09/2012WO2012106364A1 Methods and compositions for treating bacterial infections with iron chelators
08/09/2012WO2012106313A2 Ubiquitin interacting motif peptides as cancer therapeutics
08/09/2012WO2012106287A2 Methods of treating acute kidney injury with retinoc acid
08/09/2012WO2012106281A2 Multimodal trail molecules and uses in cellular therapies
08/09/2012WO2012106264A2 Treatment and prevention of bacterial vaginosis and gardnerella vaginalis infections
08/09/2012WO2012105854A2 Compositions for administration to the eye
08/09/2012WO2012105813A2 Use of icam-1 for prevention or treatment of neurological diseases
08/09/2012WO2012105223A1 Immunity activation drug
08/09/2012WO2012104838A1 Use of hgh for the treatment of small for gestational age infants under two years of age
08/09/2012WO2012104791A1 Fusion polypeptides and uses thereof
08/09/2012WO2012104766A1 A novel high affinity bivalent helically constrained peptide against cancer
08/09/2012WO2012104663A1 Composition for treatment of bone and joint disorders
08/09/2012WO2012104550A2 Use of the sigma-1 receptor for regulating ion channel expression at the post-transcriptional level
08/09/2012WO2012104516A1 Modulation of epidermo-pilosebaceous unit epithelial cell proliferation via rank
08/09/2012WO2012104462A1 Heptapeptides and the use thereof for controlling hypertension
08/09/2012WO2012104355A1 Antiviral agent containing recombinant mistletoe lectins
08/09/2012WO2012104342A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
08/09/2012WO2012104305A1 Antimicrobial 4-oxoquinolizines
08/09/2012WO2012104224A1 Caspase-2 inhibitors
08/09/2012WO2012103802A1 Liquid medicinal composition containing echinocandin antifungal agent micafungin
08/09/2012WO2012103801A1 Medicinal composition containing echinocandin antifungal agent micafungin, and preparation method and use therefor
08/09/2012WO2012103684A1 Fusion proteins and methods for treating hiv infection and aids related symptoms
08/09/2012WO2012080176A3 Pharmaceutical compositions comprising alisporivir
08/09/2012WO2012078734A3 Polypeptide derived from calcitonin receptors and methods of use
08/09/2012WO2012069836A3 Biologically active complex and its preparation
08/09/2012WO2012054500A3 Compositions for drug administration
08/09/2012WO2012052995A3 Treatment and prevention of hepatocellular carcinoma with chemokine receptor modulators
08/09/2012WO2012051567A8 Obesity-related genes and their proteins and uses thereof
08/09/2012WO2012046238A3 Erythropoietin receptor antagonists
08/09/2012WO2012040406A3 Human-adapted ha polypeptides, vaccines, and influenza treatment
08/09/2012WO2012040323A8 Multimeric il-15 soluble fusion molecules and methods of making and using same
08/09/2012WO2012036907A3 Broad spectrum antibiotic arylomycin analogs
08/09/2012WO2012027652A3 Methods and compositions for treating inflammation
08/09/2012WO2011163452A8 Treating surface of the eye disorders
08/09/2012WO2011133964A3 Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
08/09/2012WO2011133559A3 Alpha tubulin acetyltransferase
08/09/2012US20120204282 Methods and compositions for treating occular disorders
08/09/2012US20120204281 Drg11-responsive (dragon) gene family
08/09/2012US20120204280 Drg11-responsive (dragon) gene family
08/09/2012US20120204276 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis
08/09/2012US20120204273 Compositions relating to a phosphoprotein and methods of use
08/09/2012US20120203162 Method for treating neovascularization
08/09/2012US20120203102 Azulene and azaazulene systems for imaging, monitoring and therapy
08/09/2012US20120203052 Therapeutic regimen for treating cancer
08/09/2012US20120202983 Conjugates and Compositions for Cellular Delivery
08/09/2012US20120202874 Antisense oligonucleotide modulation of stat3 expression
08/09/2012US20120202873 RNAi Probes Targeting Cancer-Related Proteins
08/09/2012US20120202754 Enhanced substrates for the protease activity of serotype a botulinum neurotoxin
08/09/2012US20120202753 Inhibiting inflammation with milk oligosaccharides
08/09/2012US20120202752 Antisense Oligonucleotides
08/09/2012US20120202751 Methods of monitoring endoplasmic reticulum (er) stress response
08/09/2012US20120202750 Inhibitors of iap
08/09/2012US20120202749 Secreted frizzled related protein, sfrp, fragments and methods of use thereof
08/09/2012US20120202748 Recombinant mussel adhesive protein fp-131
08/09/2012US20120202747 Pharmaceutical composition, food or drink, and methods related thereto
08/09/2012US20120202746 Daptomycin for multiple sclerosis
08/09/2012US20120202745 Adult cerebellum-derived neural stem cells and compositions and methods for producing oligodendrocytes
08/09/2012US20120202744 Dual antagonism of endothelin type a and bradykinin b1 receptors for treating pain and preventing cartilage degradation
08/09/2012US20120202743 SUSTAINED RELEASE FORMULATIONS COMPRISING GnRH ANALOGUES
08/09/2012US20120202742 Methods and devices for the sustained release of multiple drugs
08/09/2012US20120202741 Delivery of bmp-7 and methods of use thereof
08/09/2012US20120202740 Scgb3a2 as a growth factor and anti-apoptotic agent
08/09/2012US20120202739 Gdf3 antibodies and related methods
08/09/2012US20120202738 Therapy for enteric infections
08/09/2012US20120202737 New bacitracin antibiotics
08/09/2012US20120202736 Spray-dried collectin compositions and process for preparing the same
08/09/2012US20120202735 Antimicrobial cationic peptides and formulations thereof
08/09/2012US20120202734 Antibiotic, its nucleotide sequence, methods of construction and uses thereof
08/09/2012US20120202733 Inhibition of trem receptor signaling with peptide variants
08/09/2012US20120202732 Modified aav capsid polypeptides
08/09/2012US20120202243 IN Vivo Incorporation of Unnatural Amino Acids
08/09/2012US20120202208 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
08/09/2012US20120202206 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
08/09/2012US20120201901 Topical Antibiotic Formulations
08/09/2012US20120201892 Porous-wall hollow glass microspheres as carriers for biomolecules
08/09/2012US20120201891 Transdermal delivery patch
08/09/2012US20120201883 Antiviral compositons
08/09/2012US20120201875 Stable low digestive enzyme content formulation
08/09/2012US20120201873 Controlled release formulations of lipocalin muteins
08/09/2012US20120201872 Liposomes comprising a calcium phosphate-containing precipitate
08/09/2012US20120201862 Process for the preparation of colloidal systems for the delivery of active compounds
08/09/2012US20120201858 Multiple-arm peptide compounds, methods of manufacture and use in therapy
08/09/2012US20120201857 Transdermal delivery system for therapeutics
08/09/2012US20120201855 Modified flagellin improved toll-like receptor 5 stimulating activity
08/09/2012US20120201854 Modified flagellin improved toll-like receptor 5 stimulating activity
08/09/2012US20120201840 EphA2 T-Cell Epitopes and Uses Therefor
08/09/2012US20120201839 Allergy treatment using acid treated aqueous whey protein extract
08/09/2012US20120201825 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
08/09/2012US20120201824 Compositions and Methods for Inhibiting an Oncogenic Protein to Enhance Immunogenicity
08/09/2012US20120201822 Tumor treatment
08/09/2012US20120201816 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
08/09/2012US20120201806 Liquid-retaining elastomeric compositions
08/09/2012US20120201804 Tissue kallikrein for the treatment of schizophrenia and bipolar disorder
08/09/2012US20120201803 3-substituted compounds for reducing uric acid
08/09/2012US20120201802 Method for producing reduced coenzyme q10, method for stabilizing same, and composition comprising same
08/09/2012US20120201801 Topical co-enzyme q10 formulations and methods of use
08/09/2012US20120201800 Methods and Devices for Sustained In-Vivo Release Of an Active Agent
08/09/2012US20120201792 Methods and products for manipulating hematopoietic stem cells
08/09/2012US20120201783 Compounds for the treatment of hepatitis c
1 ... 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 ... 3163